|
|||||
|
|
ADO09, a co-formulation of the amylin analogue pramlintide and the insulin analogue A21G,lowers postprandial blood glucose versus insulin lispro in type 1 diabetes |
|
| Authors: | Grit Andersen MD Grégory Meiffren PhD Susanne Famulla PhD Tim Heise MD Aymeric Ranson MSc Cyril Seroussi MSc Rosy Eloy MD Martin Gaudier PhD Richard Charvet PhD You-Ping Chan PhD Olivier Soula PhD J. Hans DeVries MD |
| Affiliation: | 1. Profil, Neuss, Germany;2. Adocia, Lyon, France |
| Abstract: | |
| Keywords: | antidiabetic drug clinical trial glucagon insulin therapy pharmacodynamics type 1 diabetes |